at Nasdaq.com (Thu, 12:01PM)
More on Myriad Genetics (MYGN +8.9%): The mixed ruling was not a surprise to many, as the Court expressed skepticism over whether human DNA extracted from the body could be patented like a mechanical invention during arguments in April. Nevertheless, it removes an overhang for the sector. Read more here: (Supreme Court Ruling).
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Nasdaq.com (Jan 22, 2015)
at Nasdaq.com (Jan 21, 2015)
at Zacks.com (Jan 16, 2015)
at Zacks.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs